APA (7th ed.) Citation

Fautrel, B., Richette, P., Roux, C., Cormier, G., Soubrier, M., Mariette, X., . . . Taisne, N. Abatacept versus tocilizumab for the treatment of rheumatoid arthritis in TNF inhibitor inadequate responders: Study protocol of the SUNSTAR randomised controlled open-label superiority trial. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Fautrel, Bruno, et al. Abatacept Versus Tocilizumab for the Treatment of Rheumatoid Arthritis in TNF Inhibitor Inadequate Responders: Study Protocol of the SUNSTAR Randomised Controlled Open-label Superiority Trial. BMJ Publishing Group.

MLA (9th ed.) Citation

Fautrel, Bruno, et al. Abatacept Versus Tocilizumab for the Treatment of Rheumatoid Arthritis in TNF Inhibitor Inadequate Responders: Study Protocol of the SUNSTAR Randomised Controlled Open-label Superiority Trial. BMJ Publishing Group.